These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1691357)

  • 41. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enalapril blunts the antinatriuretic effect of circulating noradrenaline in man.
    Lang CC; Rahman AR; Balfour DJ; Struthers AD
    J Hypertens; 1993 May; 11(5):565-71. PubMed ID: 8390529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects.
    de Leeuw PW; Hoogma RP; van Soest GA; Tchang PT; Birkenhäger WH
    J Cardiovasc Pharmacol; 1983; 5(5):731-6. PubMed ID: 6195458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
    Navis GJ; de Zeeuw D; de Jong PE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S30-4. PubMed ID: 2422491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neonatal angiotensin-converting enzyme inhibition in the rat induces persistent abnormalities in renal function and histology.
    Guron G; Adams MA; Sundelin B; Friberg P
    Hypertension; 1997 Jan; 29(1 Pt 1):91-7. PubMed ID: 9039086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
    Kamper AL; Holstein-Rathlou NH; Leyssac PP; Strandgaard S
    Am J Kidney Dis; 1996 Dec; 28(6):822-31. PubMed ID: 8957033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
    Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
    Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
    Gojanovic B; Feihl F; Liaudet L; Waeber B
    J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):1-9. PubMed ID: 18404602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of converting enzyme inhibition by enalapril on renal hemodynamics in essential arterial hypertension].
    Chaignon M; Moreau L
    Presse Med; 1988 Oct; 17(34):1745-7. PubMed ID: 2855543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
    Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA
    Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
    Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI
    Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):439-44. PubMed ID: 2444797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.